Dong Sung Bio Pharm.Co.,Ltd.

A002210

KR7002210003

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 23:00:00 26/06/2024 BST			5-day change	1st Jan Change
4,875 ^KRW	+1.25%		-0.91%	-15.36%

2023	Dong Sung Bio Pharm.Co.,Ltd. announced that it has received KRW 14 billion in funding	CI
2023	Dong Sung Bio Pharm.Co.,Ltd. announced that it expects to receive KRW 14 billion in funding	CI

Dong Sung Bio Pharm.Co.,Ltd.(KOSE:A002210) added to S&P Global BMI Index

September 24, 2018 at 05:00 am

Latest news about Dong Sung Bio Pharm.Co.,Ltd.

Dong Sung Bio Pharm.Co.,Ltd. announced that it has received KRW 14 billion in funding	23/07/23	CI
Dong Sung Bio Pharm.Co.,Ltd. announced that it expects to receive KRW 14 billion in funding	19/07/23	CI
Dong Sung Bio Pharm.Co.,Ltd.'s Equity Buyback announced on June 23, 2022, has expired.	22/09/22	CI
Tranche Update on Dong Sung Bio Pharm.Co.,Ltd.'s Equity Buyback Plan announced on June 23, 2022.	24/08/22	CI
Dong Sung Bio Pharm.Co.,Ltd. announces an Equity Buyback for 261,780 shares.	23/06/22	CI
Dong Sung Bio Pharm.Co.,Ltd. authorizes a Buyback Plan.	22/06/22	CI
Dong Sung Bio Pharm.Co.,Ltd.'s Equity Buyback announced on August 20, 2021, has expired.	18/11/21	CI
Tranche Update on Dong Sung Bio Pharm.Co.,Ltd.'s Equity Buyback Plan announced on August 20, 2021.	07/10/21	CI
Dong Sung Bio Pharm.Co.,Ltd. announced that it has received KRW 8.5 billion in funding from a group of investors	22/08/21	CI
Dong Sung Bio Pharm.Co.,Ltd. announces an Equity Buyback for 209,424 shares.	20/08/21	CI
Dong Sung Bio Pharm.Co.,Ltd. authorizes a Buyback Plan.	19/08/21	CI
Dong Sung Bio Pharm.Co.,Ltd. announced that it expects to receive KRW 8.5 billion in funding from a group of investors	12/08/21	CI
Dong Sung Bio Pharm.Co.,Ltd.'s Equity Buyback announced on March 19, 2020, has expired.	18/06/20	CI
Tranche Update on Dong Sung Bio Pharm.Co.,Ltd.'s Equity Buyback Plan announced on March 19, 2020.	21/04/20	CI
Dong Sung Bio Pharm.Co.,Ltd. announces an Equity Buyback for 233,918 shares.	19/03/20	CI
Dong Sung Bio Pharm.Co.,Ltd. authorizes a Buyback Plan.	18/03/20	CI
Dong Sung Bio Pharm.Co.,Ltd.(KOSE:A002210) added to S&P Global BMI Index	24/09/18	CI
Dongsung Pharmaceutical Co.,Ltd announced that it has received KRW 24 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm and other investors	15/04/18	CI
Dongsung Pharmaceutical Co.,Ltd announced that it expects to receive KRW 24 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm and other investors.	08/04/18	CI
Dongsung Pharmaceutical Co. Ltd. announced that it has received KRW 10 billion in funding from Synergy Partners Co., Ltd., Golden Bridge Asset Management Co., Ltd., Susung Asset Management Co., Ltd., NH Investment & Securities Co., Ltd., Investment Arm	11/07/16	CI
Dongsung Pharmaceutical Co. Ltd. announced that it expects to receive KRW 10 billion in funding from Synergy Partners Co., Ltd., Golden Bridge Asset Management Co., Ltd., Susung Asset Management Co., Ltd., NH Investment & Securities Co., Ltd., Investment Arm	10/07/16	CI
BioGaia AB Signs Exclusive Distribution Agreement with Dongsung Pharmaceutical Co. Ltd	08/05/13	CI
Dongsung Pharmaceutical Co. Ltd. announced that it has received KRW 3 billion in funding.	29/02/12	CI
Dongsung Pharmaceutical Co. Ltd. announced that it expects to receive KRW 3 billion in funding.	28/02/12	CI

Chart Dong Sung Bio Pharm.Co.,Ltd.

Duration

Period

More charts

Dongsung Pharmaceutical Co., Ltd. is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products include anti-rheumatic, anti-inflammatory analgesics, anti-inflammatory enzymes, drugs for cardiovascular system, gastrointestinal drugs, antispasmodic agents, respiratory agents, anti-histamine, dermatologicals, antibiotics, antidiarrheals, antifungals, oral hypoglycemic agents, hormones, hypnotics and others. It also produces hair dyes and cosmetics. The Company distributes its products within domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

12/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
DONG SUNG BIO PHARM.CO.,LTD.	-15.36%	79.1M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.39%	43.67B
OTSUKA HOLDINGS CO., LTD.	+28.10%	22.79B
SANDOZ GROUP AG	+21.43%	15.45B
CIPLA LIMITED	+18.82%	14.29B
ZYDUS LIFESCIENCES LIMITED	+53.37%	12.83B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-12.44%	6.52B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+15.72%	5.59B

Generic Pharmaceuticals